Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Vaccines, Inc.”

61 pharma patents match "Takeda Vaccines, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 61
Index total 30,257
Page 3 / 3

Quick answer

This filtered view shows 61 pharmaceutical patents matching "Takeda Vaccines, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

61 results for “Takeda Vaccines, Inc.” · 30,257 patents in full index Clear search

  1. US 9439959

    Chimeric influenza virus-like particles

    Takeda Vaccines, Inc. · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  2. US 9359410

    Virus like particle purification

    Takeda Vaccines, Inc. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  3. US 9308249

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  4. US 9272028

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  5. US 9211323

    Compositions and methods for administration of vaccines against dengue virus

    Takeda Vaccines, Inc. · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  6. US 9028809

    Compositions, methods and uses for expression of enterobacterium-associated peptides

    Takeda Vaccines, Inc. · Granted May 12, 2015 · Expires May 7, 2035

    granted

  7. US 9011874

    Compositions, methods and uses for poxvirus elements in vaccine constructs

    Takeda Vaccines, Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  8. US 9005632

    Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains

    Takeda Vaccines, Inc. · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  9. US 8980275

    Targeted heterologous antigen presentation on calicivirus virus-like particles

    Takeda Vaccines, Inc. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  10. US 8968996

    Compositions and methods for rapid immunization against dengue virus

    Takeda Vaccines, Inc. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  11. US 8920812

    Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS

    Takeda Vaccines, Inc. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  12. US 8871487

    Compositions, methods and uses for inducing viral growth

    Takeda Vaccines, Inc. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  13. US 8841120

    Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

    Takeda Vaccines, Inc. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.